Catalogue of Flumazenil Products
To place and order simply contact us with what you’d like to order. We’ll reply shortly (fully transactional website coming soon).
| Name (Flumazenil Transdermal Cream) | Tube Count | Flumazenil Concentration (mg/ml) | #CAS | Flumazenil Purity (%) | Weight of Tube (g) | Price ($) | Order |
|---|---|---|---|---|---|---|---|
|
*NEW – Starter System – Very Low Dose + Low Dose Flumazenil – 2 Tubes |
2 |
1 mg/ml + 4 mg/ml |
78755-81-4 |
99.9% United States Pharmacopeia Grande (USP) |
30 g |
$600.00 + Free Shipping +
Save 50$ |
|
|
Very Low Dose Flumazenil |
1 |
1 mg/ml |
78755-81-4 |
99.9% United States Pharmacopeia Grande (USP) |
30 g |
$300.00 |
|
|
Low Dose Flumazenil |
1 |
4 mg/ml |
78755-81-4 |
99.9% United States Pharmacopeia Grande (USP) |
30 g |
$350.00 |
|
|
Low Dose Flumazenil – 2 Tubes |
2 |
4 mg/ml |
78755-81-4 |
99.9% United States Pharmacopeia Grande (USP) |
30 g |
$675.00 + Free Shipping |
|
|
Low Dose Flumazenil – 3 Tubes |
3 |
4 mg/ml |
78755-81-4 |
99.9% United States Pharmacopeia Grande (USP) |
30 g |
$925.00$ + Free Shipping |
Topi-CLICK
TopiClick is the gold standard in transdermal delivery, trusted for precise dosing, consistency, and ease of use across compounded therapies.
TopiClick makes dosing simple and consistent with 1 click per dose, 4 clicks per mL, and 120 doses in every 30 g tube.
Transdermal flumazenil offers a practical alternative to both sublingual and IV administration. Compared with sublingual delivery, transdermal application provides more stable and consistent blood concentrations over time.
While IV administration delivers flumazenil directly into the bloodstream, transdermal delivery can achieve effective systemic absorption in a far more convenient, noninvasive, and patient-friendly form.
PDF. Abstract
One page abstract. A Flexible Home-Based Transdermal Flumazenil Protocol for
PAWS (Post-Acute Withdrawal Syndrome) / BIND
(Benzodiazepine-Induced Neurological Dysfunction)
Sample Patient Guides For Practicioners
Ressources for Research Centers
Case Study
Coming Soon
| Name | Flumazenil |
| Alternative names | Ro 15-1788 |
| Purity | >99% |
| Description | GABAA receptor antagonist |
| Purity | >99% |
| Chemical name | 8-Fluoro-5,6-dihydro-5-methyl-6-oxo -4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, ethyl ester |
| Molecular Weight | 303.29 |
| Chemical structure | ![Flumazenil [78755-81-4] Chemical Structure](https://cdn.hellobio.com/media/catalog/product//h/b/hb0915.png "Flumazenil [78755-81-4]") |
| Molecular Formula | C15H14FN3O3 |
| CAS Number | 78755-81-4 |
| PubChem identifier | 3373 |
| SMILES | CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1 |
| InChiKey | OFBIFZUFASYYRE-UHFFFAOYSA-N |
| Biological description | GABAA receptor antagonist, non-selective for α1, α2, α3 or α5 subunits. Binds at the benzodiazepine site. Used as a reversal agent for benzodiazepines. Reverses tolerance to benzodiazepines and restores the neuroprotective actions of diazepam in ischemia models. Flumazenil is a high-purity benzodiazepine antagonist with a proven track record in research studies exploring GABA-A receptor modulation, benzodiazepine receptor binding, and more. Not for human use. Flumazenil is used in preclinical studies to explore its role as a GABA-A receptor antagonist. It is frequently employed in receptor binding studies, as well as in research on benzodiazepine addiction and withdrawal. |
| Solubility overview | Soluble in DMSO (25mM, gentle warming) or ethanol (5mM) |
| Storage instructions | +4°C (desiccate) |
| Storage of solutions | Prepare and use solutions on the same day if possible. Store solutions at -20°C for up to one month if storage is required. Equilibrate to RT and ensure the solution is precipitate free before use. |
| Shipping Conditions | Stable for ambient temperature shipping. Follow storage instructions on receipt. |
| Important | This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
| Name | Flumazenil |
| Alternative name | Ro 15-1788 |
| Purity | >99.9% |
| Description | GABAA receptor antagonist |